Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

324 / 2,001 drugs

No. DrugBank 薬物名(臨床試験情報から抽出) KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
17-beta-Hydroxyepiandrosterone1件: 7-beta-hydroxyepiandrosterone; - - - 1件:  6  💬
28-hydroxy-2'-deoxyguanosine-- - - 1件:  6  💬
3Acamprosate1件: Acamprosate; 2件: D02780
D07058 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 2件:  6 , 206 💬
4Acetaminophen9件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen tablets; Acetaminophen/paracetamol; Multi-modal pain management [acetaminophen + gabapentin]; Oxycodone/acetaminophen; Paracetamol (acetaminophen); Tramadol /acetaminophen; Tramadol hydrochloride + acetaminophen; 1件: D00217 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
5Acetate98件: 11c-acetate; 2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester; 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Abiraterone acetate; Acetate; Bazedoxifene acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Caspofungin acetate; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Cosyntropin acetate; Cyclophosphamide/glatiramer acetate; Delmitide acetate; Depot leuprolide acetate 3.75 mg; Desmopressin acetate; Desmopressin acetate trihydrate; Device: cellulose acetate with petrolatum; Dichloroacetate; Dichloroacetate sodium; Dirucotide acetate; Edratide acetate; Etiprednol dicloacetate; Experimental glatiramer acetate; Flecainide acetate; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Gonadorelin acetate and triptorelin acetate; Human interferon beta-1a and glatiramer acetate; Hydrocortisone acetate; Hydrocortisone sodium acetate; L-lysyl-d-prolyl-l-threonine acetate; L-lysyl-d-prolyl-lthreonine acetate, lyophilisate; Lanreotide acetate; Lapaquistat acetate and current lipid-lowering treatment; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate; Leuprorelin acetate 3.75mg injection; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Macimorelin acetate; Megestrol acetate; Megestrol acetate tablet; Methylprednisolone acetate; Nomegestrol acetate; Octreotide acetate; Oxaloacetate (oaa); Phosphate and betamethasone acetate, 2 ml.; Plovamer acetate; Plovamer acetate 0.5 milligram (mg); Plovamer acetate 10 mg; Plovamer acetate 20 mg; Plovamer acetate 3 mg; Prednisolone acetate; Prednisone acetate; Prednisone acetate tablets; Procedure: warm compress prior to injection of glatiramer acetate; Sodium acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Sotrastaurin (inn) acetate; Tetracosactide acetate; Tetracosactide hexaacetate; Tocopherol acetate; Tocopheryl acetate; Triptorelin acetate and gonadorelin acetate; Ulipristal acetate; Zinc acetate; Zinc acetate (20mg/d); Zinc acetate dihydrate; Zuretinol acetate; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
6Acetohydroxamic acid2件: Acetohydroxamic acid; Acetohydroxamic acid oral tablet [lithostat]; 1件: D00220 💬 - - 2件:  6 , 251 💬
7Acetylcysteine12件: Acetylcysteine; Acetylcysteine effervescent tablets; Acetylcysteine sodium; Fluimucil (acetylcysteine); Glatiramer acetate, n-acetylcysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetylcysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); 1件: D00221 💬 - - 17件:  6 , 13, 19, 20, 34, 49, 51, 58, 85, 90, 94, 111, 164, 193, 233, 298, 299 💬
8ACR3251件: Acr325; - - - 1件:  6  💬
9Activated charcoal-1件: D03251 💬 - - 9件:  6 , 46, 50, 51, 85, 86, 96, 97, 298 💬
10Ademetionine-1件: D07128 💬 - - 2件:  6 , 93 💬
11Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins-- - - 3件:  2 ,  6 , 46 💬
12Agomelatine2件: Agomelatine; Agomelatine or piacebo; 1件: D02578 💬 3件: HTR2C, MTNR1A, MTNR1B 💬 6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 1件:  6  💬
13Alanine7件: 3-(3,4-dihydroxyphenyl)-l-alanine; Alanine; Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala); Beta-alanine; Beta-alanine supplementation; L-3-(3,4-dihydroxyphenyl)alanine; L-alanine; 1件: D00012 💬 - - 4件:  6 , 13, 298, 299 💬
14Albendazole2件: Albendazole; Albendazole (eskazole); 1件: D00134 💬 - - 11件:  5 ,  6 ,  7 , 28, 51, 67, 86, 96, 97, 114, 127 💬
15Allopurinol4件: Allopurinol; Allopurinol sandoz 100 mg, tabletten; Allopurinol sodium; Azathioprine and allopurinol; 1件: D00224 💬 1件: XDH 💬 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 6件:  6 , 46, 57, 66, 96, 97 💬
16Altropane2件: Altropane; Altropane®; - - - 1件:  6  💬
17Amantadine13件: 240mg amantadine hcl er tablets; 320mg amantadine hcl er tablets; Ads-5102 (extended release amantadine hcl); Amantadine; Amantadine 300 mg; Amantadine hcl er; Amantadine hcl extended release; Amantadine hcl extended release capsule; Amantadine hydrochloride; Amantadine hydrochloride (hcl); Amantadine sulfate; Determination of drug effects through amantadine cessation; Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj; 2件: D00777
D07441 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 4件:  6 ,  8 , 13, 127 💬
18Ambroxol2件: Ambroxol; Ambroxol hydrochloride; 1件: D07442 💬 - - 2件:  6 , 19 💬
19Ammonia4件: 13n-ammonia; Ammonia; Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3); Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82; 1件: D02916 💬 - - 4件:  6 , 17, 86, 88 💬
20Amoxicillin8件: Amoxicillin; Amoxicillin and clavulanic acid; Amoxicillin and tetracycline; Amoxicillin hydrate; Amoxicillin, metronidazole and tetracycline; Clartihromycin, amoxicillin, and omeprazole; Lansoprazole, amoxicillin, clarithromycin; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); 3件: D00229
D02925
D07452 💬
- - 9件:  6 , 19, 46, 63, 84, 96, 97, 222, 299 💬
21Ampicillin-3件: D00204
D01251
D02119 💬
- - 5件:  2 ,  6 , 13, 84, 299 💬
22Ampreloxetine3件: Ampreloxetine; Ampreloxetine chydrochloride; Ampreloxetine hydrochloride; 1件: D11688 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
23ANX-510-- - - 3件:  6 , 265, 288 💬
24Aplindore2件: Aplindore; Aplindore mr tablets; - - - 1件:  6  💬
25Apomorphine21件: 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate; 6aß - apomorphine-10,11-diol hydrochloride hemihydrate; Apomorphine; Apomorphine 0.25% (2.5mg/ml); Apomorphine hcl injection; Apomorphine hydrochloride; Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed; Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed; Apomorphine hydrochloride hemihydrate; Apomorphine hydrocloride; Apomorphine hydrocloride hemihydrate; Apomorphine infusion; Apomorphine nasal powder; Continuous apomorphine infusion; Dopaminergic agonist + apomorphine; Injection of apomorphine; Iv apomorphine; S.c. apomorphine; Subcutaneous apomorphine; 2件: D02004
D07460 💬
2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
26Aripiprazole1件: Aripiprazole; 1件: D01164 💬 4件: DRD2, DRD3, HTR1A, HTR2A 💬 12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 2件:  6 , 206 💬
27Armodafinil1件: Armodafinil; 1件: D03215 💬 1件: SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 3件:  6 , 13, 84 💬
28Aspartame-1件: D02381 💬 2件: TAS1R2, TAS1R3 💬 2件: Carbohydrate digestion and absorption, Taste transduction 5件:  6 , 13, 67, 86, 230 💬
29Atomoxetine1件: Atomoxetine; 2件: D02574
D07473 💬
1件: SLC6A2 💬 1件: Synaptic vesicle cycle 3件:  6 ,  8 , 13 💬
30AV-1011件: Av-101; - - - 1件:  6  💬
31Azathioprine38件: Azathioprine; Azathioprine (aza); Azathioprine (aza) caps; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine (imuran) 50 mg overencapsulated tablet; Azathioprine - ratiopharm 50 mg; Azathioprine / 6 mercaptopurine; Azathioprine 25 mg; Azathioprine and allopurinol; Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine or mycophenolate mofetil; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Azathioprine/prednisone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Continuation of azathioprine; Corticosteroid and azathioprine; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Early immunosuppressants (azathioprine, methotrexate); Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Overencapsulated azathioprine (imuran) 50 mg tablet; Prednisone - azathioprine; Products containing azathioprine or 6-mercaptopurine; Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); 2件: D00238
D03033 💬
- - 20件:  6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬
32Bavisant3件: Bavisant; Bavisant dihydrochloride monohydrate; Bavisant hydrochloride monohydrate; 1件: D09870 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
33Benserazide8件: Benserazide; Benserazide hydrochloride; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa/benserazide; Levodopa/benserazide 100/25 mg; 1件: D03082 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
34Benzofuran2件: Benzofuran; R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride; - - - 1件:  6  💬
35BIA26件: 200 mg bia 6-512; 25 mg bia9 1067; 50 mg bia 9 1067; Bia; Bia 3-202; Bia 3-202 (200 mg); Bia 5-1058; Bia 6-512; Bia 6-512 100 mg; Bia 6-512 100 mg dose; Bia 6-512 200 mg dose; Bia 6-512 25 mg; Bia 6-512 25 mg dose; Bia 6-512 400 mg; Bia 6-512 50 mg dose; Bia 9-1067; Bia 9-1067 (test); Bia 9-1067 15 mg; Bia 9-1067 25 mg; Bia 9-1067 30 mg; Bia 9-1067 5 mg; Bia 9-1067 micronized; Bia 9-1067 non-micronized; Bia-5-1058; Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale; [14c]-bia 9-1067; - - - 2件:  6 , 86 💬
36Bifenthrin-- - - 2件:  6 , 46 💬
37Botulinum toxin type A6件: Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Botulinum toxin type a 200u; Botulinum toxin type a 300u; Botulinum toxin type a infiltrations; Clostridium botulinum toxin type a; 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 13件:  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬
38Botulinum Toxin Type B3件: Botulinum toxin type b; Botulinum toxin type b (2500 units / vial); Botulinum toxin type b (myobloc); 1件: D02735 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 3件:  2 ,  6 , 51 💬
39Bromocriptine2件: Bromocriptine; Bromocriptine and other dopamine agonists; 2件: D00780
D03165 💬
2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 2件:  6 , 74 💬
40BTRX-2460401件: Btrx-246040; - - - 1件:  6  💬
41Bumetanide2件: Bumetanide; Bumetanide white, oblong, scored tablet; 1件: D00247 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 2件:  6 , 158 💬
42Buspirone2件: Buspirone; Buspirone hydrochloride; 2件: D00702
D07593 💬
2件: DRD2, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 2件:  6 , 51 💬
43Butylphthalide2件: Butylphthalide; Dl-3-n-butylphthalide (nbp); - - - 4件:  2 ,  6 , 18, 22 💬
44Cabergoline3件: Cabergoline; Cabergoline teva; Pasireotide with or without cabergoline; 1件: D00987 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 , 74, 75 💬
45Caffeine6件: Caffeine; Caffeine 100 mg; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Other: caffeine; 2件: D00528
D01453 💬
11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 9件:  2 ,  6 , 13, 21, 46, 78, 96, 97, 265 💬
46Calcium34件: Amorphous calcium carbonate; Ascal(r) / carbasalate calcium; Atorvastatin calcium; Calcitriol & calcium; Calcium; Calcium and cholecalciferol; Calcium and vitamin d combination; Calcium carbonate; Calcium carbonate and alphacalcidol; Calcium carbonate d; Calcium channel blockers; Calcium citrate; Calcium citrate with vitamin d2; Calcium gluconate; Calcium lactate; Calcium levofolinate; Calcium rosuvastatin; Calcium, dietary; Carbasalate calcium; Crestor tablets (calcium rosuvastatin) film-coated tablets; Crystalline calcium supplements; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Low molecular weight heparin calcium injection; Other: calcium stable isotope; Other: determination of calcium intake by a dietician interview; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; Other: serum calcium concentrations results; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Vidofludimus calcium; Vidofludimus calcium dihydrate; - - - 27件:  6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
47Cannabidiol11件: Avcn583601 (3% cannabidiol cream); Cannabidiol; Cannabidiol (cbd); Cannabidiol , synthetic form; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol botanical drug substance (cbd bds); Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg; Cannabidiol vaginal suppository; Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 19件:  2 ,  6 ,  8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
48Capsaicin5件: Capsaicin; Capsaicin challenge; Capsaicin vapor; Other: challenge agent: capsaicin; Qutenza (8% capsaicin); 1件: D00250 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 5件:  2 ,  6 , 19, 86, 226 💬
49Captopril2件: Captopril; Spironolactone captopril carvedilol; 1件: D00251 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 8件:  6 , 17, 46, 86, 96, 97, 107, 271 💬
50Carbidopa85件: Accordion pill carbidopa/levodopa; Accordion pill ¿ carbidopa/levodopa 50/400 mg; Accordion pill ¿ carbidopa/levodopa 50/500 mg; Accordion pill? carbidopa/levodopa 50/400 mg; Accordion pill? carbidopa/levodopa 50/500 mg; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Anhydrous carbidopa; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa; Carbidopa (fu); Carbidopa 20 mg; Carbidopa 200mg oral dose; Carbidopa 27.5 mg; Carbidopa 65 mg capsule; Carbidopa and levodopa 25mg/100mg; Carbidopa and levodopa tablets, usp; Carbidopa anidra; Carbidopa fu; Carbidopa inn; Carbidopa levodopa; Carbidopa monohydrate; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa-4'-monophosphate; Carbidopa-levodopa; Carbidopa-levodopa 25 mg-100 mg oral tablet; Carbidopa/l-dopa; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Carbidopamonohydraat; Combination product: l-dopa 70mg/carbidopa 7mg; Comparator: carbidopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel; Entacapone and carbidopa; Foscarbidopa; Foscarbidopa and foslevodopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 10/100 mg; Immediate release carbidopa/levodopa 25/100 mg; Ir cd-ld (carbidopa-levodopa) tablets; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa intestinal gel (lcig); Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/carbidopa; Levodopa/carbidopa (4:1); Levodopa/carbidopa (ld/cd); Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Nd0612 (levodopa/carbidopa solution); Odm-101 105mg carbidopa; Odm-101 65mg carbidopa; Oral levodopa and carbidopa; Oral levodopa/carbidopa; Sinemet (carbidopa/levodopa); Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Stalevo (levodopa/carbidopa/entacapone); Wd-1603 carbidopa and levodopa extended-release tablets; Wd-1603 carbidopa/levodopa extended-release tablets; Xp21279 and carbidopa (experimental); 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
51Carbon monoxide3件: Carbon monoxide; Inhaled carbon monoxide; Other: carbon monoxide-bubbled mediums; 1件: D09706 💬 - - 7件:  6 , 13, 53, 70, 85, 86, 298 💬
52Carnosine3件: Carnosine; Carnosine supplementation; Carnosine, capsulle, 2 g/day, 8 weeks; - - - 2件:  6 , 13 💬
53Carvedilol2件: Carvedilol; Spironolactone captopril carvedilol; 2件: D00255
D03415 💬
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  6 , 57, 86, 113, 210 💬
54Ceftriaxone1件: Ceftriaxone; 2件: D00924
D07659 💬
- - 3件:  2 ,  6 , 97 💬
55CEP-13475件: Cep-1347; Cep-1347 10mg; Cep-1347 50mg; Cep1347; Cep1347 25mg; - - - 1件:  6  💬
56Chloride ion-- - - 25件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬
57Cholecalciferol11件: 5000 iu of cholecalciferol; Calcium and cholecalciferol; Cholecalciferol; Cholecalciferol (vitamin d3); Cholecalciferol (vitamind3); Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol and c. xanthorrhiza; Cholecalciferol concentrate; Cholecalciferol concentrate (water-dispersible form); Cholecalciferol, vitamin d3; 1件: D00188 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 23件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
58Citalopram8件: 20mg daily citalopram; Bupropion & citalopram; Citalopram; Citalopram 20mg; Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; 2件: D00822
D07704 💬
1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 6件:  6 ,  8 , 13, 18, 46, 127 💬
59Clarithromycin8件: A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine; Biaxin ( clarithromycin); Clarithromycin; Clarithromycin (not used as of 4/2020); Lansoprazole, amoxicillin, clarithromycin; Lansoprazole, clarithromycin, amoxycillin; Rifabutin, clarithromycin, and clofazimine; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); 1件: D00276 💬 - - 8件:  6 , 63, 84, 96, 97, 222, 228, 299 💬
60Clenbuterol3件: Clenbuterol; Clenbuterol hcl; Clenbuterol hydrochloride; 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  1 ,  2 ,  6 , 13, 256 💬
61Clonazepam1件: Clonazepam; 1件: D00280 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
62Clonidine5件: Clonidine; Clonidine hcl cf 0,150 mg, tabletten; Clonidine hydrochloride; Device: clonidine (catapressan); Procedure: arginine and clonidine stimulation testing; 2件: D00281
D00604 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 2件:  6 , 78 💬
63Clozapine1件: Clozapine; 1件: D00283 💬 11件: ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 8件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 1件:  6  💬
64Cobalt chloride-- - - 1件:  6  💬
65Cocoa3件: Cocoa; Dark chocolate (85% cocoa); White chocolate (0% cocoa); - - - 1件:  6  💬
66Creatine4件: Creatine; Creatine monohydrate; Creatine-13c; Pyruvate, creatine, niacinamide; - - - 12件:  1 ,  2 ,  5 ,  6 ,  8 , 13, 46, 49, 50, 113, 156, 201 💬
67Cyanocobalamin-4件: D00166
D03615
D03616
D03617 💬
- - 5件:  6 , 13, 201, 229, 299 💬
68Cycloserine-1件: D00877 💬 - - 1件:  6  💬
69Cysteine17件: Acetylcysteine; Acetylcysteine effervescent tablets; Cysteine; Cysteine hydrochloride; Glatiramer acetate, n-acetylcysteine; Intravenous and oral n-acetyl cysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetyl cysteine; N acetylcysteine; N-acetyl cysteine; N-acetyl cysteine (nac); N-acetyl-cysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); 2件: D00026
D02326 💬
- - 11件:  6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
70D-Serine2件: D-serine; D-serine (~2g/day); - - - 1件:  6  💬
71Dalfampridine6件: Dalfampridine; Dalfampridine er; Dalfampridine-er 10mg; Dalfampridine-er 5mg; Other: withdrawal of dalfampridine-er 10mg; Sustained-release oral dalfampridine; 1件: D04127 💬 4件: KCNA4, KCNC3, KCND2, KCND3 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 5件:  3 ,  4 ,  6 , 13, 14 💬
72Darifenacin3件: Darifenacin; Darifenacin (bay79-4998); Oxybutynin and darifenacin; 2件: D01699
D03654 💬
1件: CHRM3 💬 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 2件:  6 , 13 💬
73Deanol2件: Deanol; Deanol pyroglutamate; 1件: D07777 💬 - - 1件:  6  💬
74Deferiprone11件: Deferiprone; Deferiprone (ferriprox); Deferiprone 20mg; Deferiprone 30mg; Deferiprone 600 mg delayed release tablet; Deferiprone 80 mg/ml oral solution; Deferiprone 80 mg/ml oral solution (ferriprox); Deferiprone dr; Deferiprone oral solution; Deferiprone treated; Ferrprox (deferiprone); 1件: D07416 💬 - - 6件:  2 ,  6 , 18, 120, 122, 233 💬
75Delorazepam-1件: D07784 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 3件:  6 , 46, 97 💬
76Desipramine4件: Administration of a high dose of desipramine; Administration of a low dose of desipramine; Desipramine; Desipramine (dmi); 2件: D00812
D07791 💬
2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 4件:  6 , 17, 120, 156 💬
77Desmopressin9件: Ddavp (desmopressin); Desmopressin; Desmopressin acetat; Desmopressin acetate; Desmopressin acetate trihydrate; Desmopressin intranasal; Desmopressin oral melt; Desmopressine; Desmopressine nasal spray 10 mg/ml, flacon 60 doses; 2件: D00291
D02235 💬
2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 6件:  6 , 64, 72, 75, 225, 288 💬
78Dexmedetomidine10件: Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine hydrochloride infusion; Dexmedetomidine with ropivacaine; Fentanyl (low dose) + dexmedetomidine; Scopolamine, atropine, edaravone and dexmedetomidine; 2件: D00514
D01205 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
79Dextromethorphan10件: Dextromethorphan; Dextromethorphan 30 mg; Dextromethorphan and caffeine; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; 3件: D00848
D03742
D03744 💬
6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 11件:  2 ,  6 ,  8 , 13, 21, 46, 78, 85, 96, 97, 156 💬
80Dextrose, unspecified form-- - - 18件:  2 ,  6 , 13, 49, 50, 56, 60, 65, 70, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
81Dichloroisoproterenol-- - - 2件:  6 , 299 💬
82Dihydrotachysterol-1件: D00299 💬 1件: VDR 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 1件:  6  💬
83Dipivefrin2件: Dipivefrin; Dipivefrine; 1件: D02349 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
84Dipraglurant1件: Dipraglurant; - - - 1件:  6  💬
85Doconexent-- - - 10件:  6 , 46, 48, 49, 90, 94, 113, 240, 299, 301 💬
86Domperidone3件: Domperidone; Domperidone (drug); Levodopa and domperidone; 2件: D01745
D07868 💬
1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 5件:  6 , 13, 17, 51, 230 💬
87Donepezil7件: Donepezil; Donepezil hci (drug); Donepezil hydrochloride; Donepezil sandoz; Other: [11c]donepezil pet; Pridia (donepezil hydrochloride) 5mg; Prior donepezil 5mg; 2件: D00670
D07869 💬
1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 9件:  5 ,  6 , 13, 46, 78, 124, 127, 156, 206 💬
88Dopamine16件: A-dopamine; Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors; Behavioral: role of dopamine; Bromocriptine and other dopamine agonists; Cerebral dopamine neurotrophic factor; Continuous release dopamine agonists; Dopamine; Dopamine agent; Dopamine agonist treatment; Dopamine agonists; Dopamine agonists (pramipexole, ropirinole); Dopaminergic agonist + apomorphine; Dopaminergic agonists; Procedure: embryonic dopamine cell implant surgery; Recombinant human cerebral dopamine neurotrophic factor; Usual dopaminergic per os treatment; 2件: D00633
D07870 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 ,  7 , 74 💬
89Doxepin2件: Doxepin; Doxepin and zopiclone; 2件: D00814
D07875 💬
3件: HRH1, SLC6A2, SLC6A4 💬 5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
90Droxidopa2件: Droxidopa; Droxidopa 100 mg [northera]; 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件:  5 ,  6 , 17 💬
91Duloxetine3件: Duloxetine; Duloxetine hydrochloride; Duloxetine hydrochloride (hci); 2件: D01179
D07880 💬
2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 13 💬
92Eliprodil1件: Eliprodil; - - - 1件:  6  💬
93Elobixibat1件: Elobixibat; 1件: D10796 💬 1件: SLC10A2 💬 1件: Bile secretion 1件:  6  💬
94Eltoprazine3件: Eltoprazine; Eltoprazine hcl; Eltoprazine hydrochloride; - - - 1件:  6  💬
95Entacapone15件: Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa, levodopa, entacapone; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa/entacapone; Entacapone; Entacapone 400mg oral dose; Entacapone and carbidopa; Entacapone inn; Levodopa, carbidopa, entacapone; Levodopa-carbidopa-entacapone; Levodopa/carbidopa/entacapone; Over-encapsulated entacapone tablets; Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapone); V1512 and entacapone; 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 2件:  6 , 17 💬
96EPI-5891件: Epi-589; - - - 2件:  2 ,  6  💬
97Epigallocatechin gallate2件: Coconut oil and epigallocatechin gallate; Epigallocatechin gallate; - - - 9件:  6 ,  8 , 13, 17, 28, 85, 113, 206, 299 💬
98Ergoloid mesylate-1件: D02268 💬 6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件:  6  💬
99Erythromycin3件: Erythromycin; Erythromycine; Oral erythromycin; 9件: D00140
D00851
D01361
D02009
D02184
D02523
D02524
D02525
D04054 💬
- - 5件:  6 , 36, 164, 228, 291 💬
100Erythropoietin4件: Erythropoietin; Erythropoietin human recombinant (eporh); Recombinant human erythropoietin; Recombinant human erythropoietin(rhepo); 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 10件:  2 ,  6 , 13, 18, 22, 46, 47, 70, 95, 96 💬
101Escitalopram4件: Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; 3件: D02567
D07704
D07913 💬
1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 3件:  2 ,  6 , 13 💬
102Eszopiclone1件: Eszopiclone; 1件: D02624 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 3件:  6 , 13, 46 💬
103Exametazime2件: Exametazime; Technetium (99mtc) exametazime; 1件: D01109 💬 - - 1件:  6  💬
104Exenatide5件: Exenatide; Exenatide 10 micrograms; Exenatide 5 micrograms; Exenatide extended release 2mg (bydureon); Exenatide pen injector [bydureon]; 1件: D04121 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 4件:  6 , 17, 193, 233 💬
105Famotidine2件: Famotidine; Famotidine 20 mg; 1件: D00318 💬 1件: HRH2 💬 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 4件:  6 , 46, 86, 98 💬
106Febuxostat1件: Febuxostat; 1件: D01206 💬 1件: XDH 💬 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 3件:  2 ,  6 , 13 💬
107Fenamole-1件: D04139 💬 - - 3件:  6 , 13, 160 💬
108Fesoterodine1件: Fesoterodine; 1件: D07226 💬 2件: CHRM2, CHRM3 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
109Filgrastim7件: Ep2006 (filgrastim); Filgrastim; Filgrastim (g-csf); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Pegfilgrastim; 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
110Finasteride1件: Finasteride; 1件: D00321 💬 1件: SRD5A2 💬 2件: Prostate cancer, Steroid hormone biosynthesis 1件:  6  💬
111Fipamezole7件: Fipamezole; Fipamezole hydrochloride; Fipamezole hydrochloride 30 mg oral disintegrating tablets; Fipamezole hydrochloride 60 mg oral disintegrating tablets; Fipamezole hydrochloride 90 mg oral disintegrating tablets; Fipamezole odt; Fipamezole odt cohort 2; - - - 2件:  6 , 17 💬
112Flecainide2件: Flecainide; Flecainide acetate; 2件: D00638
D07962 💬
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
113Florbenazine F-18-- - - 1件:  6  💬
114Florbetaben (18F)-1件: D10002 💬 - - 1件:  6  💬
115Fludeoxyglucose (18F)-- - - 13件:  5 ,  6 ,  7 , 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 💬
116Fludrocortisone1件: Fludrocortisone; 2件: D00986
D07967 💬
1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 3件:  6 , 17, 81 💬
117Flumazenil7件: 11c-flumazenil; Diagnostic test: pet with [11c]flumazenil; Flumazenil; Pet with 11c-flumazenil; Transdermal flumazenil (added 4/2020); [11c]flumazenil; [18f]flumazenil; 1件: D00697 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 5件:  6 , 13, 17, 18, 206 💬
118Flutemetamol4件: Diagnostic test: flutemetamol f18 injection; Flutemetamol; Flutemetamol f18; Vizamyl (flutemetamol(f-18)); - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
119Flutemetamol (18F)-1件: D10231 💬 - - 5件:  5 ,  6 ,  7 , 17, 127 💬
120Folic acid5件: Folic acid; Folic acid or folate; Folic acid, vitamin b6, vitamin b12; Methotrexate and folic acid; Rituximab, mtx, folic acid; 1件: D00070 💬 - - 5件:  6 , 13, 46, 49, 84 💬
121Foliglurax3件: Foliglurax; Foliglurax 10 mg (treatment a); Foliglurax 30 mg (treatment b); - - - 1件:  6  💬
122Foscarbidopa2件: Foscarbidopa; Foscarbidopa and foslevodopa; - - - 1件:  6  💬
123Gabapentin9件: Gabapentin; Gabapentin prescriptions; Gabapentina; Gabapentina kern pharma; Gabapentine; Gabapentine 300mg; Multi-modal pain management [acetaminophen + gabapentin]; Multi-modal pain management [valium + gabapentin]; Transdermal fentanyl matrix, gabapentin; 1件: D00332 💬 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 5件:  6 , 13, 19, 70, 298 💬
124Galantamine2件: Galantamine; Galantamine hydrobromide; 2件: D02173
D04292 💬
1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 2件:  6 , 127 💬
125gamma-Hydroxybutyric acid-- - - 2件:  6 , 149 💬
126Ginkgo biloba3件: Ginkgo biloba; Ginkgo biloba pills sig: 300mg/tid; Standardized ginkgo biloba extract (egb 761 (r); - - - 4件:  6 , 13, 18, 90 💬
127Glutathione11件: Glutathione; Glutathione sodium; Gsh (glutathione); Inhaled reduced glutathione; Intranasal glutathione - (in)gsh; Oral glutathione; Oral reduced l-glutathione; Reduced glutathione; Reduced glutathione 100mg; Reduced glutathione 200mg; Reduced glutathione sodium salt; 2件: D00014
D00031 💬
- - 2件:  6 , 299 💬
128Glycerin2件: Glycerine; Other: glycerine gel; 1件: D00028 💬 - - 6件:  6 , 13, 79, 265, 316, 317 💬
129Glycerol phenylbutyrate1件: Glycerol phenylbutyrate; 1件: D10127 💬 - - 3件:  6 , 251, 299 💬
130Gold7件: Gold; Gold nanocrystals; Mtx goldshield tablets; Other: comparator: cpet cycle ergometer (gold standard); Procedure: quantiferon-tb gold assay; Procedure: repair of cdh w/sis gold; Sodium aurothiomalate (intramuscular gold); - - - 38件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
131GPI-14851件: Gpi 1485; - - - 1件:  6  💬
132Grapefruit2件: Grapefruit; Grapefruit juice; - - - 5件:  6 , 46, 50, 83, 97 💬
133Green tea leaf1件: Green tea leaf; 1件: D06903 💬 - - 5件:  6 , 17, 28, 46, 96 💬
134Guar gum2件: Guar gum; Hydrolyzed guar gum; 1件: D04403 💬 - - 1件:  6  💬
135Heptaminol2件: Heptaminol; Heptaminol hydrochloride; 1件: D07158 💬 - - 1件:  6  💬
136Hydrocortisone31件: 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Combination oral budesonide and rectal hydrocortisone; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortef (hydrocortisone); Dual release hydrocortisone (plenadren); Hydrocortisone; Hydrocortisone (solucortef); Hydrocortisone 100mg/ml; Hydrocortisone 10mg; Hydrocortisone 10mg tablet; Hydrocortisone 10mg tablets; Hydrocortisone 20mg tablets; Hydrocortisone acetate; Hydrocortisone cream; Hydrocortisone cream 1%; Hydrocortisone cream 10mg/g fna fagron; Hydrocortisone hydrogen succinate; Hydrocortisone modified release capsules; Hydrocortisone roussel; Hydrocortisone sodium acetate; Hydrocortisone sodium phosphate; Hydrocortisone sodium succinate; Hydrocortisone tablet 2.5 mg; Hydrocortisone takeda, tabletter; Mesalazine with hydrocortisone sodium succinate; Other: hydrocortisone; Procedure: hydrocortisone withdrawal; Solu-cortef (hydrocortisone); Subcutaneous hydrocortisone; Subcutaneous hydrocortisone 10mg; 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 9件:  6 , 46, 53, 75, 78, 81, 83, 97, 299 💬
137Hydrocortisone cypionate-1件: D00976 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件:  6 , 81, 83 💬
138Hydrocortisone succinate-1件: D01442 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件:  6 , 81, 83 💬
139Hydrogen8件: 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate; Hydrocortisone hydrogen succinate; Hydrogen; Hydrogen peroxide; Lisuride hydrogenmaleate; Methylprednisolon-21-hydrogensuccinat, natriumsalz; Other: hydrogen peroxide; Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt); - - - 7件:  5 ,  6 , 13, 17, 83, 97, 226 💬
140Idebenone2件: Idebenone; Idebenone 150 mg film-coated tablets; 1件: D01750 💬 - - 5件:  6 , 13, 18, 113, 302 💬
141Inosine2件: 1) inosine 5'-monophosphate; Inosine; 1件: D00054 💬 - - 5件:  2 ,  6 , 13, 17, 85 💬
142Iodide I-123-- - - 2件:  2 ,  6  💬
143Ioflupane I-123-1件: D10014 💬 - - 4件:  2 ,  5 ,  6 , 17 💬
144Ipratropium5件: Bromure d'ipratropium; Ipratropium; Ipratropium bromide (drug); Nebulized combination ipratropium bromide with salbutamol; Nebulized ipratropium bromide; 1件: D02212 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件:  6 , 86 💬
145Iproniazid1件: Iproniazid; 1件: D02579 💬 2件: MAOA, MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
146Isoflurane1件: Isoflurane; 1件: D00545 💬 - - 1件:  6  💬
147Isoxaflutole-- - - 9件:  5 ,  6 , 13, 46, 81, 113, 122, 149, 299 💬
148Isradipine5件: Dynacirc cr (isradipine); Isradipine; Isradipine cr 10mg; Isradipine cr 20mg; Isradipine cr 5mg; 1件: D00349 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
149Istradefylline8件: Istradefylline; Istradefylline ( kw-6002); Istradefylline (kw-6002); Istradefylline 20 mg; Istradefylline 20 mg or 40 mg; Istradefylline 40 mg; Kw-6002 (istradefylline); Rifampin 300mg bid + istradefylline 40mg day 8 only; 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
150ITI-2141件: Iti-214; - - - 1件:  6  💬
151Josamycin-1件: D01235 💬 - - 2件:  6 , 13 💬
152Ketamine6件: Esketamine; Esketamine hydrochloride; Ketamine; Multi-modal pain management [intravenous ketamine]; S-ketamine; S-ketamine & midazolam; 2件: D00711
D08098 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
153Lactobacillus plantarum4件: Daily ingestion of lactobacillus plantarum ps128; Lactobacillus plantarum; Lactobacillus plantarum ps128; Probiotic-lactobacillus plantarum ps128; - - - 3件:  6 , 97, 156 💬
154Lactose4件: 2'-fucosyllactose; Lactose; Lactose in water; Lactose monohydrate; 2件: D00046
D03226 💬
- - 6件:  2 ,  6 , 13, 97, 228, 310 💬
155Lenomorelin-- - - 3件:  6 , 78, 299 💬
156Leptin5件: Hu leptin (a-100); Human recombinant leptin (metreleptin); Leptin; Metreleptin; R-methuleptin; - - - 2件:  6 , 265 💬
157Leucine8件: Administration of stable isotope-labelled leucine-; Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels; Essential amino acid intake + leucine vs total aa supplement; L-leucine; Leucine; N acetyl l leucine; N-acetyl-l-leucine; Other: 13c6 leucine; 1件: D00030 💬 - - 10件:  5 ,  6 ,  7 , 19, 96, 97, 127, 283, 284, 299 💬
158Levetiracetam1件: Levetiracetam; 1件: D00709 💬 1件: SV2A 💬 1件: ECM-receptor interaction 4件:  2 ,  4 ,  6 , 13 💬
159Levodopa111件: Accordion pill carbidopa/levodopa; Accordion pill ¿ carbidopa/levodopa 50/400 mg; Accordion pill ¿ carbidopa/levodopa 50/500 mg; Accordion pill? carbidopa/levodopa 50/400 mg; Accordion pill? carbidopa/levodopa 50/500 mg; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Behavioral: levodopa or acupuncture; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa and levodopa 25mg/100mg; Carbidopa and levodopa tablets, usp; Carbidopa levodopa; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa-levodopa; Carbidopa-levodopa 25 mg-100 mg oral tablet; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Comparator: levodopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel; Foscarbidopa and foslevodopa; Foslevodopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 10/100 mg; Immediate release carbidopa/levodopa 25/100 mg; Intravenous levodopa; Ir cd-ld (carbidopa-levodopa) tablets; Iv levodopa; Levodopa; Levodopa (dc.it) (fu); Levodopa (delivered intravenously); Levodopa (drug), intraduodenal administration; Levodopa (l-dopa); Levodopa (l-dopa) + standard care; Levodopa / benserazid; Levodopa / benserazide 200 + 50 mg; Levodopa 100 mg / benserazide 25 mg; Levodopa 100 mg a cap; Levodopa 125 mg a cap; Levodopa 150 mg a cap; Levodopa 25mg/100mg; Levodopa 75 mg a cap; Levodopa acute challenge; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa and decarboxylase inhibitor; Levodopa and domperidone; Levodopa benserazide madopar; Levodopa benserazide teva italia; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa cr (controlled release); Levodopa cyclops; Levodopa dc.it fu; Levodopa dispersible; Levodopa infusion; Levodopa inn; Levodopa mr; Levodopa powder for inhalation; Levodopa tablet; Levodopa test; Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa, decarboxylase inhibitor and comt inhibitor; Levodopa-4'-monophosphate; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa intestinal gel (lcig); Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/benserazide; Levodopa/benserazide 100/25 mg; Levodopa/benzeraside; Levodopa/benzerazide; Levodopa/carbidopa; Levodopa/carbidopa (4:1); Levodopa/carbidopa (ld/cd); Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Levodopa/ddci; Levodopa/dopa decarboxylase inhibitor; Melevodopa; Melevodopa and decarboxylase inhibitor; Nacom levodopa+cardidopa; Nd0612 (levodopa/carbidopa solution); Oral levodopa and carbidopa; Oral levodopa/carbidopa; Rasagiline mesylate with levodopa; Safinamide + levodopa; Sinemet (carbidopa/levodopa); Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Stalevo (levodopa/carbidopa/entacapone); Tvp-1012 (1 mg/day) with levodopa; Wd-1603 carbidopa and levodopa extended-release tablets; Wd-1603 carbidopa/levodopa extended-release tablets; 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
160Levomefolic acid-1件: D09353 💬 - - 1件:  6  💬
161Liatermin2件: Liatermin; Liatermin (r-methugdnf); 1件: D04727 💬 - - 1件:  6  💬
162Lidocaine11件: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Heparin & alkalinized lidocaine bladder instillation; Lidocaine; Lidocaine 1% injectable solution; Lidocaine 2% without vessel constrictor; Lidocaine injection 2%; Lidocaine patch 5%; Lidocaine releasing intravesical system - liris®; Local anesthesia (lidocaine hydrochloride); 3件: D00358
D02086
D08127 💬
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
163Linoleic acid3件: Linoleic acid; Linoleic acid supplementation; Linoleic acid/oleic acid; - - - 6件:  6 , 13, 75, 76, 222, 299 💬
164Liraglutide1件: Liraglutide; 1件: D06404 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 3件:  6 , 75, 193 💬
165Lisuride8件: Continuous subcutaneous lisuride infusion; Lisuride; Lisuride hydrogenmaleate; Lisuride transdermal system; Lisuride tts; Lisuride tts 10cm²; Lisuride tts 20cm²; Transdihydrolisuride; 2件: D01462
D08132 💬
3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 2件:  6 , 86 💬
166Lithium citrate1件: Lithium citrate; 1件: D04749 💬 - - 5件:  2 ,  5 ,  6 ,  7 ,  8  💬
167Lixisenatide1件: Lixisenatide; 1件: D09729 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件:  6  💬
168Lovastatin5件: Lovastatin; Lovastatin 60 mg; Lovastatin ™; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin; 1件: D00359 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
169Lubiprostone1件: Lubiprostone; 1件: D04790 💬 1件: CLCN2 💬 1件: Mineral absorption 4件:  6 , 13, 290, 299 💬
170Magnesium19件: (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; Magnesium; Magnesium aspartate; Magnesium aspartate hydrochloride; Magnesium citrate; Magnesium gluconate; Magnesium hydroxide; Magnesium oxide; Magnesium sulfate; Magnesium with ropivacaine; Mineral boost (magnesium); Nexium (esomeprazole magnesium); Omeprazole magnesium; Saroglitazar magnesium 2 mg; Saroglitazar magnesium 4 mg; Sodium picosulfate, magnesium oxide and citric acid; Sodium picosulfate/magnesium citrate laxative; Sulfate, magnesium; - - - 17件:  6 , 11, 13, 46, 51, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬
171Magnesium oxide2件: Magnesium oxide; Sodium picosulfate, magnesium oxide and citric acid; 1件: D01167 💬 - - 3件:  6 , 166, 291 💬
172Maltodextrin3件: Maltodextrin; Maltodextrin fiber supplement; Resistant maltodextrin; 1件: D02329 💬 - - 4件:  6 , 13, 96, 97 💬
173Mannitol7件: Dp mannitol; Idpm: inhaled dry powder mannitol; Inhaled dry powder mannitol; Inhaled mannitol; Mannitol; Mannitol + pulmozyme; Mannitol inhalation powder; 1件: D00062 💬 - - 4件:  6 , 60, 96, 299 💬
174Masitinib12件: Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib (ab1010); Masitinib 100 mg tablets; Masitinib 100mg; Masitinib 200 mg tablets; Masitinib 200mg; Masitinib 3 mg; Masitinib 6.0 mg; Masitinib mesylate; 1件: D10229 💬 1件: KIT 💬 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
175Mavoglurant1件: Mavoglurant; - - - 2件:  6 , 206 💬
176Medical Cannabis-- - - 8件:  2 ,  6 , 13, 46, 90, 96, 97, 271 💬
177Medium-chain triglycerides-- - - 3件:  6 , 96, 318 💬
178Melatonin11件: 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin; Melatonin cr; Melatonin pr; Melatonin(circadin®); Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.; 1件: D08170 💬 2件: MTNR1A, MTNR1B 💬 2件: Circadian entrainment, Neuroactive ligand-receptor interaction 11件:  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
179Melevodopa2件: Melevodopa; Melevodopa and decarboxylase inhibitor; 1件: D07304 💬 - - 1件:  6  💬
180Melperone2件: Melperone; Melperone hcl; 1件: D07309 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
181Memantine5件: Memantine; Memantine (drug); Memantine (ebixa); Memantine hydrochloride; Memantine hydrochloride oral solution; 2件: D04905
D08174 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 7件:  2 ,  6 ,  8 , 13, 49, 127, 205 💬
182Mesdopetam2件: Mesdopetam; Mesdopetam (irl790); - - - 1件:  6  💬
183Metformin21件: 750 mg metformin and 7.5 g l-citrulline daily p.o.; Glucophage (metformin); L-citrulline and metformin & l-citrulline; Metformin; Metformin (generic); Metformin 500mg; Metformin and metformin & l-citrulline; Metformin hcl; Metformin hydrochloride; Metformin treatment; Metformin/cp-690,550; Metformina; Metformina - 500 30 compresse 500 mg; Metformine; Metformine arrow 500mg; Metformine hcl 500 pch; Metformine sandoz 850 mg filmomhulde tabletten; Other: metformin; Pioglitazone or metformin; Sitagliptin and metformin; [metformina]; 2件: D00944
D04966 💬
2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
184Methylphenidate11件: D-methylphenidate; Methylphenidate; Methylphenidate (mpd); Methylphenidate (overencapsulated); Methylphenidate 10mg tablets; Methylphenidate hydrochloride; Methylphenidate modified release; Methylphenidate modified release 20 mg; Methylphenidate modified release 30 mg; Methylphenidate modified release 40 mg; Methylphenidate, fluoxetin, risperidone; 2件: D01296
D04999 💬
2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 7件:  6 , 13, 34, 84, 113, 179, 206 💬
185Methylprednisolone35件: Administration of rituximab and methylprednisolone; Corticosteroid treatment (methylprednisolone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Infliximab, methylprednisolone, methotrexate; Interferon-beta-1a (avonex) plus methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Intravenous methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methotrexate + methylprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone (mp); Methylprednisolone (mp) or prednisone (pred); Methylprednisolone (or other glucocorticoid); Methylprednisolone (solu-medrol); Methylprednisolone 1250 mg/24h x3 days; Methylprednisolone acetate; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone mylan générique; Methylprednisolone or budesonide; Methylprednisolone or prednisolone; Methylprednisolone po; Methylprednisolone pulse; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Oral methylprednisolone 625 mg/24h x3 days; Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; 6件: D00407
D00751
D00979
D05000
D05001
D05002 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
186Midazolam7件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Midazolam; Midazolam 2 mg; Midazolam 3 mg; Midazolam injection; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; 3件: D00550
D00696
D05028 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 11件:  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 298 💬
187Midodrine2件: Midodrine; Midodrine hydrochloride; 2件: D01307
D08220 💬
3件: ADRA1A, ADRA1B, ADRA1D 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 3件:  6 , 17, 58 💬
188Minocycline8件: Combination of minocycline and mtx or mtx alone; Glatiramer acetate with minocycline; Lovastatin, then minocycline/lovastatin; Minocycline; Minocycline 100 mg film-coated tablets; Minocycline 100mg; Minocycline hydrochloride; Minocycline, then minocycline/lovastatin; 2件: D00850
D05045 💬
- - 14件:  2 ,  6 ,  8 , 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 💬
189Minodronic acid1件: Minodronic acid; - - - 4件:  6 , 46, 93, 95 💬
190Mirabegron1件: Mirabegron; 1件: D09535 💬 1件: ADRB3 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 3件:  6 , 13, 226 💬
191Mitoquinone1件: Mitoquinone; - - - 3件:  6 , 13, 97 💬
192Moclobemide1件: Moclobemide; 1件: D02561 💬 1件: MAOA 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
193Modafinil5件: Armodafinil; Modafinil; Modafinil 50mg; Over-encapsulated modafinil; Provigil (modafinil); 1件: D01832 💬 - - 4件:  6 , 13, 49, 93 💬
194Moxifloxacin6件: Avelox- moxifloxacin; Moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride; Moxifloxacin infusion; Moxifloxacina cloridrato; 2件: D00874
D08237 💬
- - 8件:  2 ,  6 , 46, 49, 85, 86, 240, 299 💬
195Muscimol1件: Muscimol; - - - 1件:  6  💬
196Nabilone3件: Cesamet™ (nabilone); Nabilone; Nabilone 0.25 mg; 1件: D05099 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 2件:  6 , 13 💬
197Nalmefene1件: Nalmefene; 1件: D05111 💬 3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
198Naloxone12件: Naloxone; Naloxone hydrochloride; Naloxone hydrochloride dihydrate; Oxycodone naloxone prolonged release tablets; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets; Oxycodone/naloxone prolonged release tablets 10 mg /5 mg; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20 mg /10 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg; 2件: D01340
D08249 💬
3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 2件:  6 , 226 💬
199Naltrexone6件: 4.5 mg naltrexone; Low dose naltrexone; Low-dose naltrexone; Naltrexone; Naltrexone hydrochloride; Naltrexone-hcl; 2件: D02095
D05113 💬
3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 13件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
200Nebicapone1件: Nebicapone; - - - 1件:  6  💬
201Nelotanserin1件: Nelotanserin; 1件: D09645 💬 1件: HTR2A 💬 5件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 1件:  6  💬
202Neridronic Acid1件: Neridronic acid; - - - 1件:  6  💬
203Niacin6件: Dose-establishing study 1 niacin 250mg; Dose-establishing study 1 niacin 500mg; Dose-establishing study 2 niacin 500mg; Niacin; Niacin first; Niacinamide; 1件: D00049 💬 - - 4件:  6 , 78, 79, 265 💬
204Nicotinamide3件: Eh301 (nicotinamide riboside/pterostilbene); Nicotinamide; Nicotinamide riboside; 1件: D00036 💬 - - 9件:  2 ,  5 ,  6 , 13, 18, 49, 67, 162, 191 💬
205Nicotinamide riboside2件: Eh301 (nicotinamide riboside/pterostilbene); Nicotinamide riboside; - - - 4件:  2 ,  6 , 18, 191 💬
206Nicotine9件: Nicotine; Nicotine gum; Nicotine nasal spray 10 mg/ml (0.5 mg/spray); Nicotine patch; Nicotine transdermal patch; Nicotinell; Nicotinell 17,5 mg/24-stunden-pflaster; Nicotinell 35 mg/24-stunden-pflaster; Transdermal nicotine; 3件: D03365
D05156
D05157 💬
16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 7件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 2件:  6 , 84 💬
207Nilotinib9件: Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib (tasigna); Nilotinib 150 mg; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 50 mg; Nilotinib hydrochloride monohydrate; 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 5件:  6 ,  8 , 34, 51, 86 💬
208Nitrogen3件: Device: perform three multiple breath nitrogen washout tests (n2-mbw-test); Nitrogen; Procedure: functional hepatic nitrogen clearance; 1件: D00083 💬 - - 6件:  5 ,  6 , 17, 171, 211, 299 💬
209Nortriptyline2件: Nortriptyline; Nortriptyline hydrochloride; 2件: D00816
D08288 💬
2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 226 💬
210Omeprazole19件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Clartihromycin, amoxicillin, and omeprazole; Diclofenac + omeprazole; Dimebon + omeprazole; Esomeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Nexium (esomeprazole magnesium); Omeprazole; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 20mg; Omeprazole 20mg bid; Omeprazole 40 mg; Omeprazole 40mg capsule; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Rifaximin+omeprazole+miralax; 4件: D00455
D01207
D05259
D05261 💬
2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 16件:  6 ,  8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
211Ondansetron3件: Ondansetron; Ondansetron 8 mg film-coated tablets; Ondansetron hydrochloride dihydrate; 2件: D00456
D00678 💬
5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 2件: Serotonergic synapse, Taste transduction 3件:  6 , 97, 231 💬
212Opicapone2件: Opicapone; Opicapone (opc); 1件: D10825 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 1件:  6  💬
213Oxybuprocaine1件: Oxybuprocaine; 2件: D01768
D08319 💬
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件:  6  💬
214Oxybutynin3件: Oxybutynin; Oxybutynin and darifenacin; Oxybutynin hydrochloride; 2件: D00465
D00722 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 2件:  6 , 13 💬
215Oxycodone17件: Extended-release oxycodone; Oxycodone; Oxycodone by patient-controlled analgesia (pca); Oxycodone depot ”sandoz”, depot tablets; Oxycodone hydrochloride; Oxycodone naloxone prolonged release tablets; Oxycodone orion; Oxycodone/acetaminophen; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets; Oxycodone/naloxone prolonged release tablets 10 mg /5 mg; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20 mg /10 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg; Pr oxycodone; 3件: D03783
D05312
D05462 💬
3件: OPRD1, OPRK1, OPRM1 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 7件:  6 , 13, 46, 70, 226, 231, 298 💬
216Oxygen39件: Behavioral: respiratory and exercise therapy with supplemental oxygen; Combination product: hyperbaric oxygen therapy-; Continuous oxygen; Device: auto-titrating oxygen system; Device: capacity of muscular oxygen extraction; Device: high flow nasal oxygen cannula; Device: hyperbaric oxygen; Device: intermittent exposure to oxygen via oro-nasal mask; Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation; Device: oxygen; Device: oxygen saturation; Device: standard oxygen therapy/ra; Diagnostic test: maximum oxygen uptake; Helium / oxygen mixed gas inhalation therapy; Medical air vs oxygen; Medical grade oxygen; Nitric oxide plus oxygen; Other: 60% oxygen; Other: air - oxygen; Other: hyperbaric oxygen; Other: hyperbaric oxygen therapy; Other: muscle oxygenation; Other: optional blood-oxygen-level dependent functionalmri; Other: oxygen; Other: oxygen (2liter/min); Other: oxygen (4liter/min); Other: oxygen - air; Other: oxygen supplementation; Oxygen; Oxygen 40 %; Oxygen supplementation; Oxygen, liquid; Perfluorinated gas/oxygen mixture; Procedure: hyperbaric oxygen; Procedure: hyperbaric oxygen therapy; Procedure: long term oxygen therapy; Procedure: oxygen flow at the optic nerve head measurement; Procedure: supplemental oxygen via a mask; Standard analgesia use [oxygen]; 1件: D00003 💬 - - 18件:  6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
217Oxytocin8件: Intranasal oxytocin; Intranasal oxytocin (in-oxt); Oxytocin; Oxytocin (oxt) continuous; Oxytocin 24iu; Oxytocin 48iu; Oxytocin synthetic; Synthetic oxytocin; 1件: D00089 💬 1件: OXTR 💬 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 5件:  6 , 127, 193, 206, 226 💬
218Pardoprunox2件: Pardoprunox; Pardoprunox hydrochloride; 1件: D09397 💬 3件: DRD2, DRD3, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 1件:  6  💬
219Paroxetine4件: Paroxetine; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp; Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp; 4件: D02260
D02362
D05374
D05375 💬
1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 3件:  6 , 13, 46 💬
220Perampanel3件: 2 mg perampanel; 4 mg perampanel; Perampanel; 1件: D08964 💬 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 3件:  2 ,  6 , 144 💬
221Pergolide1件: Pergolide; 2件: D00502
D08339 💬
2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
222Phenelzine-2件: D00505
D08349 💬
2件: MAOA, MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
223Phenylbutyric acid-1件: D05868 💬 - - 12件:  2 ,  3 ,  6 ,  8 , 15, 93, 94, 231, 244, 251, 297, 299 💬
224Piclozotan1件: Piclozotan; - - - 1件:  6  💬
225Pilocarpine5件: Diagnostic test: iontophoresis sessions in forearm of subjects with pilocarpine; Pilocarpine; Pilocarpine hydrochloride; Pilocarpine nitrate 5%; Procedure: pilocarpine; 3件: D00525
D02200
D05478 💬
2件: CHRM2, CHRM3 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 3件:  6 , 53, 299 💬
226Pimavanserin5件: Active drug: pimavanserin 17mg (2 strength tablets); Pimavanserin; Pimavanserin (acp-103); Pimavanserin tartrate; Pimavanserin tartrate (acp-103); - - - 1件:  6  💬
227Pioglitazone6件: Actos (pioglitazone); Pioglitazone; Pioglitazone 15 mg; Pioglitazone and tretinoin; Pioglitazone or metformin; Tretinoin and pioglitazone hcl; 2件: D00945
D08378 💬
1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
228Piribedil2件: Piribedil; Piribedil (clarium); 1件: D07305 💬 2件: DRD2, DRD3 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
229Pitolisant3件: Bf2.649 (pitolisant); Pitolisant; Pitolisant oral tablets; 1件: D10749 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 2件:  6 , 193 💬
230Pittsburgh Compound B3件: Other: pittsburgh compound b [11c]-pib; Pittsburgh compound b; Pittsburgh compound b (c-11 pib); - - - 2件:  6 , 127 💬
231Polyethylene glycol6件: 2l polyethylene glycol/ascorbic acid; C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker; Polyethylene glycol; Polyethylene glycol 3350; Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker; Treatment with polyethylene glycol (macrogol 4000); 1件: D03370 💬 - - 11件:  6 , 13, 46, 65, 78, 96, 97, 235, 240, 276, 299 💬
232Posiphen1件: Posiphen; - - - 1件:  6  💬
233Potassium carbonate-1件: D02038 💬 - - 3件:  6 , 96, 291 💬
234Pramipexole28件: Cimetidine plus dexpramipexole; Dexpramipexole; Dexpramipexole (dose 1); Dexpramipexole (dose 2); Dexpramipexole dichydrochloride; Dexpramipexole dihydrochloride; Dopamine agonists (pramipexole, ropirinole); Mirapex (pramipexole); P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Pramipexole; Pramipexole 0.125 mg tablets; Pramipexole 0.5 mg tablets; Pramipexole dihydrochloride; Pramipexole dihydrochloride extended-release tablets; Pramipexole dihydrochloride monohydrate; Pramipexole dihydrochloride monohydrate extended release; Pramipexole er; Pramipexole extended release; Pramipexole extended release tablet; Pramipexole hydrochloride sustained-release tablet (siforl®) specification: 0.26mg/ tablet (in pramipexole); Pramipexole immediate release; Pramipexole immediate release tablet; Pramipexole ir; Pramipexole or ropinirole; Pramipexole sr; Praxol hydrochloride sustained release tablet specification: 0.375mg/ tablet (in pramipexole hydrochloride); R(+) pramipexole dihydrochloride monohydrate; 2件: D00559
D05575 💬
3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 2件:  2 ,  6  💬
235Prednisone73件: 0 mg prednisone; 5 mg prednisone; 5-aminosalicylic acid(5-asa) and/or prednisone; Adalimumab, plus prednisone; Azathioprine/prednisone; Chinese herb prescription granule plus prednisone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Enalapril valsartan methylprednisone; Glucocorticoid (prednisone or prednisolone); Granulocyte-colony stimulating factor (g-csf) and prednisone; Hormone (prednisone); Hydroxychloroquine + prednisone; Ir prednisone; Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Methylprednisone; Mr prednisone; Mycophenolate mofetil plus lower dose of prednisone; Oral prednisone; Oral prednisone 5mg; Other: prednisone; Over encapsulated prednisone; Prednisolone/prednisone; Prednisone; Prednisone (and methylprednisolone); Prednisone + inhibace/cozaar; Prednisone - azathioprine; Prednisone 0,5 mg/kg orally on alternate days; Prednisone 1 mg; Prednisone 15 mg; Prednisone 2 mg; Prednisone 3 mg; Prednisone 4 mg; Prednisone 5 mg; Prednisone 5 mg tablets; Prednisone 7.5 mg; Prednisone acetate; Prednisone acetate tablets; Prednisone alone; Prednisone and belimumab; Prednisone and cyclophosphamide; Prednisone and mycophenolate mofetil; Prednisone and ustekinumab treatment; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone capsules; Prednisone discontinuation; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Prednisone, ciclosporin and mycophenolate mofetil; Prednisone, cyclophosphamide; Prednisone, fk506, mmf; Prednisone, low dose rituximab; Prednisone, methylprednisolone,cyclophosphamides; Prednisone/prednisolone; Procedure: thymectomy plus prednisone; Rayos (delayed-release prednisone); Sotatercept with prednisone boost; Tacrolimus combined with prednisone; Thalidomide, cyclophosphamide and prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Ursodeoxycholic acid+low dose glucocorticoid(prednisone); 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 47件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
236Preladenant4件: Preladenant; Preladenant 10 mg tablet; Preladenant 2 mg tablet; Preladenant 5 mg tablet; 1件: D09717 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
237Pridopidine3件: Pridopidine; Pridopidine (90 mg); Pridopidine hydrochloride; 1件: D09953 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 3件:  2 ,  6 ,  8  💬
238Propanoic acid6件: (+)-(s)-2-(6-methoxynaphthalen-2-yl) propanoic acid; (minus)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate; Ph. eur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; Pheur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; Pheur.: (2s)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid; Propanoic acid; 1件: D02310 💬 - - 2件:  6 , 271 💬
239Propofol5件: Device: propofol dosage; Intubated with propofol (ip); Procedure: sedation with iv propofol; Propofol; Propofol-lipuro; 1件: D00549 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
240Propranolol5件: Atenolol or propranolol; Losartan and atenolol or propranolol; Propranolol; Propranolol hcl cf 40 mg tablet; Propranolol treatment; 2件: D00483
D08443 💬
3件: ADRB1, ADRB2, ADRB3 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 6件:  6 , 158, 167, 227, 278, 296 💬
241Pyridostigmine2件: Pyridostigmine; Pyridostigmine bromide; 1件: D00487 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 4件:  3 ,  6 , 11, 256 💬
242Pyridoxine4件: Pyridoxine; Pyridoxine 10mg; Pyridoxine 10mg bp; Pyridoxine plus prednisolone; 2件: D02179
D08454 💬
- - 3件:  6 , 93, 145 💬
243Pyrimethamine2件: Fansidar (pyrimethamine and sulfadoxine); Pyrimethamine; 1件: D00488 💬 - - 10件:  2 ,  4 ,  6 , 19, 46, 51, 65, 96, 97, 265 💬
244Quetiapine2件: Extended-release quetiapine fumarate; Quetiapine; 2件: D00458
D08456 💬
2件: DRD2, HTR2A 💬 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 2件:  6 , 13 💬
245Raclopride2件: 11c-raclopride; Raclopride; - - - 4件:  5 ,  6 ,  7 , 17 💬
246Ramelteon1件: Ramelteon; 1件: D02689 💬 2件: MTNR1A, MTNR1B 💬 2件: Circadian entrainment, Neuroactive ligand-receptor interaction 3件:  6 ,  8 , 46 💬
247Rasagiline16件: 1.0 mg rasagiline mesylate; Group r rasagiline; Group r+ad rasagiline + antidepressant; P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),; P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),; Rasagiline; Rasagiline 1 mg capsule; Rasagiline 1mg tablet; Rasagiline 2 mg tablet; Rasagiline mesilate; Rasagiline mesylate; Rasagiline mesylate 1.0 mg; Rasagiline mesylate plus mirapex; Rasagiline mesylate with levodopa; Rasagiline mesylate with requip; Rasagiline tablets; 3件: D02562
D08469
D10829 💬
1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 6件:  2 ,  5 ,  6 , 13, 17, 66 💬
248Remifentanil1件: Remifentanil; 2件: D01177
D08473 💬
1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 2件:  6 , 70 💬
249Repaglinide2件: Repaglinide; Repaglinide and insulin; 1件: D00594 💬 2件: ABCC8, KCNJ11 💬 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 3件:  6 , 21, 299 💬
250Reynoutria multiflora root-- - - 1件:  6  💬
251Rifampicin1件: Rifampicin; 1件: D00211 💬 - - 8件:  6 , 13, 17, 46, 84, 86, 93, 299 💬
252Rifaximin10件: Rifaximin; Rifaximin 550 mg; Rifaximin delayed release (dr); Rifaximin delayed release 400 mg film coated tablet; Rifaximin delayed release tablets; Rifaximin eir; Rifaximin oral tablet; Rifaximin+omeprazole+miralax; Rifaximin-eir; Rifaximina; 1件: D02554 💬 - - 7件:  6 , 65, 94, 96, 97, 99, 296 💬
253Rivastigmine9件: Exelon patch (rivastigmine transdermal system); Rivastigmine; Rivastigmine capsule; Rivastigmine cf; Rivastigmine luye transdermal patch- 9.5mg/24h; Rivastigmine patch 9.5 cm2; Rivastigmine transdermal patch; Rivastigmine transdermal system; Rivastigmine transdermal system 13.3 mg/24 h; 2件: D02558
D03822 💬
1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 3件:  5 ,  6 , 13 💬
254Ropinirole27件: Hp-3000 (ropinirole hydrochloride patch); Hp-3000(ropinirole hydrochloride patch); Pramipexole or ropinirole; Ropinirole; Ropinirole (as hydrochloride); Ropinirole controlled-release (requip cr) for rls; Ropinirole cr 2mg tablet; Ropinirole cr 8mg tablet; Ropinirole hydrochloride; Ropinirole hydrochloride extended-release tablet; Ropinirole hydrochloride extended-release tablet placebo; Ropinirole hydrochloride prolonged release; Ropinirole immediate release; Ropinirole implant; Ropinirole ir; Ropinirole ir tablets; Ropinirole monotherapy; Ropinirole oral product; Ropinirole pr; Ropinirole pr, 2mg; Ropinirole pr/xr; Ropinirole pr/xr tablets; Ropinirole prolonged release; Ropinirole prolonged release/extended release(pr/xr); Ropinirole xl; Ropinirole xl (formerly cr); Ropinirole/l-dopa; 2件: D00784
D08489 💬
3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 4件:  2 ,  6 , 74, 309 💬
255Rosuvastatin8件: Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Rosuvastatin; Rosuvastatin 10 mg; Rosuvastatin 20mg; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Rosuvastatine eg; 2件: D01915
D08492 💬
1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 11件:  6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
256Rotigotine17件: Ly03003 ( rotigotine, extended-release microspheres); Ly03003 (rotigotine extended release microspheres for intramuscular [im] injection); Ly03003( the name of rotigotine); Ly03003(rotigotine,extended-release microspheres); Other: rotigotine; Rotigotine; Rotigotine (reference product pr 2.1.1); Rotigotine (test product pr 2.3.1); Rotigotine hydrochloride; Rotigotine nasal spray; Rotigotine transdermal patch; Rotigotine transdermal patch 2mg/24h(10cm2); Rotigotine transdermal patch 4mg/24h (20cm2); Rotigotine transdermal patch 6mg/24h (30cm2); Rotigotine transdermal patch 8mg/24h (40cm2); Rotigotine tts (test); Rotigotine, extended-release microspheres; 1件: D05768 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
257Safinamide12件: Me2125 (safinamide mesilate); Safinamide; Safinamide (as add-on therapy); Safinamide + levodopa; Safinamide metansolfonato; Safinamide metansolfonato (12 weeks); Safinamide methanesulfonate; Safinamide methanesulfonate 100mg; Safinamide methanesulfonate 150mg; Safinamide methansulfonate; Safinamide, mao-b inhibitor; Xadago (safinamide); 1件: D10158 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
258Sage8件: Device: massage with a spiky ball; Sage; Sage leaf; Sage-217; Sage-718; Thn102 dosage a; Thn102 dosage b; Thn102 dosage c; - - - 1件:  6  💬
259Saracatinib2件: Saracatinib; Saracatinib difumarate; 1件: D09664 💬 2件: ABL1, SRC 💬 46件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 3件:  6 , 89, 272 💬
260Sarcosine2件: Sarcosine; Sarcosine capsule; - - - 1件:  6  💬
261Sargramostim4件: Gm-csf (granulocyte-macrophage colony-stimulating factor, sargramostim); Gm-csf [leukine (sargramostim)]; Sargramostim; Sargramostim (leukine); 1件: D05803 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 7件:  6 , 28, 60, 62, 96, 229, 285 💬
262Sarizotan4件: Sarizotan; Sarizotan hc1; Sarizotan hcl; Sarizotan hydrochloride; - - - 2件:  6 , 156 💬
263Selegiline3件: Orally disintegrating selegiline (zelapar); Selegiline; Selegiline hcl 5 pch; 2件: D00785
D03731 💬
1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
264Semaglutide1件: Semaglutide; 1件: D10025 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 1件:  6  💬
265SEP-3638561件: Sep-363856; - - - 1件:  6  💬
266Serine4件: D-serine; D-serine (~2g/day); L-serine; Serine; 1件: D00016 💬 - - 3件:  2 ,  6 , 86 💬
267Sertraline1件: Sertraline; 2件: D00825
D02360 💬
1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 206 💬
268Sevoflurane3件: Intubated with sevoflurane (is); Sevoflurane; Sevoflurane anesthetics; 1件: D00547 💬 - - 6件:  6 , 21, 22, 34, 98, 296 💬
269Sildenafil32件: 20 mg sildenafil citrate by mouth; 5% sildenafil cream; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); G04be03- sildenafil - sildenafil (citrato); Mono-therapy with sildenafil; Oral sildenafil; Other: standard of care sildenafil; Sildenafil; Sildenafil (50 mg); Sildenafil (acute-1 hour); Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil (subchronic-4 weeks); Sildenafil 20 mg tablets; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil 40mg oral capsule; Sildenafil and losartan; Sildenafil by injection; Sildenafil citrate; Sildenafil citrate (uk-92,480); Sildenafil filmtabletten; Sildenafil singly or in association with bosentan; Sildenafil therapy; Sildenafilo; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; 2件: D02229
D08514 💬
1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
270Silicon2件: Device: nj-tube: silicon ed tube; Silicon; - - - 1件:  6  💬
271Silodosin1件: Silodosin; 1件: D01965 💬 1件: ADRA1A 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 2件:  6 , 13 💬
272Simvastatin21件: Encapsulated simvastatin tablets; Ezetimibe+simvastatin drug combination; Other: simvastatin; Simvastatin; Simvastatin 20 mg; Simvastatin 20mg/5ml oral suspension; Simvastatin 40 mg; Simvastatin 40 mg film-coated tablets; Simvastatin 40 mg tablets; Simvastatin 40mg; Simvastatin alternova; Simvastatin in relapsing remitting multiple sclerosis; Simvastatin susp.; Simvastatin treatment for 28 days; Simvastatin-ratiopharm; Simvastatin-ratiopharm®;